Sprouty proteins act ubiquitously as signaling integrators and inhibitors of receptor tyrosine kinase (RTK) activated pathways. Among the four Sprouty isoforms, Sprouty2 is a key regulator of growth factor signaling in several neurological disorders. High protein levels correlate with reduced survival of glioma patients. We recently demonstrated that abrogating its function inhibits tumor growth by overstimulation of ERK and induction of DNA replication stress. The important role of Sprouty2 in the proliferation of malignant glioma cells prompted us to investigate its subcellular localization applying super-resolution fluorescence and immunoelectron microscopy. We found that cytoplasmic Sprouty2 is not homogenously distributed but localized...
Sprouty2 is a feedback regulator that controls the Ras/Raf/MEK/extracellular signal-regulated kinase...
Glioblastoma multiforme (GBM) is a deadly brain cancer for which survival outcomes have not signific...
Independent scientific achievements have led to the discovery of aberrant splicing patterns in oncog...
Background: Sprouty2 (SPRY2), a feedback regulator of receptor tyrosine kinase (RTK) signaling, has ...
Glioblastoma multiforme (GBM) is the most severe type of human brain tumor, with a poor prognosis an...
Dysregulation of receptor tyrosine kinase-induced pathways is a critical step driving the oncogenic ...
Mammalian Sprouty (Spry) genes function to regulate Receptor Tyrosine Kinase (RTK) activity by eithe...
Graduate Program in Science for Aging/박사Sprouty2 proteins function as inhibitors of receptor tyrosin...
AbstractAs negative regulators of receptor tyrosine kinase-mediated signalling, Sprouty proteins ful...
Glioblastomas remain the deadliest brain tumour, with a dismal ∼12-16-month survival from diagnosis....
Glioblastomas remain the deadliest brain tumour, with a dismal ∼12-16-month survival from diagnosis....
Epidermal growth factor receptor (EGFR) mutation and overexpression promote tumorigenesis in multipl...
AbstractBackground: Growth factors and their receptor tyrosine kinases play pivotal roles in develop...
M.Sc. Jongwhi ParkMedical University of Innsbruck, Dissertation, 2018OeBB(VLID)252996
Sprouty (Spry) proteins function as inhibitors of receptor tyrosine kinase signaling mainly by inter...
Sprouty2 is a feedback regulator that controls the Ras/Raf/MEK/extracellular signal-regulated kinase...
Glioblastoma multiforme (GBM) is a deadly brain cancer for which survival outcomes have not signific...
Independent scientific achievements have led to the discovery of aberrant splicing patterns in oncog...
Background: Sprouty2 (SPRY2), a feedback regulator of receptor tyrosine kinase (RTK) signaling, has ...
Glioblastoma multiforme (GBM) is the most severe type of human brain tumor, with a poor prognosis an...
Dysregulation of receptor tyrosine kinase-induced pathways is a critical step driving the oncogenic ...
Mammalian Sprouty (Spry) genes function to regulate Receptor Tyrosine Kinase (RTK) activity by eithe...
Graduate Program in Science for Aging/박사Sprouty2 proteins function as inhibitors of receptor tyrosin...
AbstractAs negative regulators of receptor tyrosine kinase-mediated signalling, Sprouty proteins ful...
Glioblastomas remain the deadliest brain tumour, with a dismal ∼12-16-month survival from diagnosis....
Glioblastomas remain the deadliest brain tumour, with a dismal ∼12-16-month survival from diagnosis....
Epidermal growth factor receptor (EGFR) mutation and overexpression promote tumorigenesis in multipl...
AbstractBackground: Growth factors and their receptor tyrosine kinases play pivotal roles in develop...
M.Sc. Jongwhi ParkMedical University of Innsbruck, Dissertation, 2018OeBB(VLID)252996
Sprouty (Spry) proteins function as inhibitors of receptor tyrosine kinase signaling mainly by inter...
Sprouty2 is a feedback regulator that controls the Ras/Raf/MEK/extracellular signal-regulated kinase...
Glioblastoma multiforme (GBM) is a deadly brain cancer for which survival outcomes have not signific...
Independent scientific achievements have led to the discovery of aberrant splicing patterns in oncog...